Substance-Related Disorders D019966

Diseases [C] » Chemically-Induced Disorders [C25] » Substance-Related Disorders

Psychiatry and Psychology [F] » Mental Disorders [F03] » Substance-Related Disorders

Description

Disorders related to substance use or abuse.   MeSH

Hierarchy View

Subtype Terms (15)

Alcohol-Related Disorders
32 drugs (27 approved, 5 experimental)

Amphetamine-Related Disorders
30 drugs (24 approved, 6 experimental)

Cocaine-Related Disorders
152 drugs (116 approved, 36 experimental)

Drug Overdose
11 approved drugs

Inhalant Abuse
 

Marijuana Abuse
49 drugs (39 approved, 10 experimental)

Marijuana Use
7 drugs (4 approved, 3 experimental)

Narcotic-Related Disorders
7 approved drugs

Neonatal Abstinence Syndrome
15 drugs (7 approved, 8 experimental)

Phencyclidine Abuse
 

Psychoses, Substance-Induced
2 approved drugs

Substance Abuse, Intravenous
10 drugs (9 approved, 1 experimental)

Substance Abuse, Oral
46 drugs (39 approved, 7 experimental)

Substance Withdrawal Syndrome
56 drugs (46 approved, 10 experimental)

Tobacco Use Disorder
87 drugs (58 approved, 29 experimental)


Phase 3 Indicated Drugs (3)


Organization Involved with Phase 4 Indications (67)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.